Importantly, CRC patients with high levels of effector Tregs exhibited poorer prognosis, while a better prognosis was reported in CRC patients with predominantly higher levels of non-Tregs, who also showed high mRNA levels of TGF-β, TNF-α and IL-12 [45]. Here, TGFB1 is linked to colorectal carcinoma.